Clinical aspects of cancer treatment and new biochemical mechanisms of the drug Ukrain.

K N Uglyanitsa, L I Nefyodov, L M Karayedova, J W Nowicky, W Brzosko

Journal: Drugs under experimental and clinical research 2001;26(5-6):239-47

PMID: 11345031

Abstract

A random group of 50 patients in tumor stages T1-3N0-2M0 was selected from breast cancer patients and given Ukrain therapy by intravenous injection. Twenty-five patients received a total dose of 50 mg Ukrain (5 mg every second day, 10 injections altogether). Twenty-five patients received a total dose of 100 mg Ukrain (10 mg every second day, 10 injections altogether).

Address: Oncology Department of Grodno Higher Medical School, Grodno, Belarus.

Link outs

Free resources

Medical:

https://medlineplus.gov/breastcancer.html

MeSH Terms: Alkaloids, Antineoplastic Agents, Phytogenic, Berberine Alkaloids, Blood Cell Count, Breast Neoplasms, Female, Humans, Immunity, Cellular, Injections, Intravenous, Macrophages, NAD, Phenanthridines